Clinical Trials · NCT01982630
Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 87
- Start date
- Nov 2013
- Locations
- See registry
- Primary endpoint
- Number of Participants Experiencing Adverse Events (AEs) in Part 1